Trials / Active Not Recruiting
Active Not RecruitingNCT02116335
Endothelin Receptor Function and Acute Stress
Endothelin Receptor Function and Acute Stress (End-Stress)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 320 (estimated)
- Sponsor
- Augusta University · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Our bodies respond differently to stress. Animal studies by the investigators have found that endothelin-1 plays a role in regulating blood pressure in response to stress. This study is an extension of the investigators previous animal work to evaluate the role of endothelin-1 during stress in humans.
Detailed description
Using a salt sensitive animal model of prehypertension, the Dahl S rat,the investigators have previously published that acute stress elicits a pressor response that is accompanied by an increase in 8 isoprostane and endothelin-1. However, the pressor response is suppressed by endothelin A/B receptor antagonism. Moreover, the investigators have identified that the increase in 8-isoprostane occurs downstream of endothelin receptor activation. These data indicate that endothelin receptor activation is a main player In the pressor response to acute stress in pre-hypertensive animals; however, this phenomenon has yet to be elucidated in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bosentan | Stress response and vascular function will be assessed 3 days following 125 mg twice per day of Bosentan |
| DRUG | Placebo | Stress response and vascular function will be assessed 3 days following twice per day placebo |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2025-12-01
- Completion
- 2026-01-01
- First posted
- 2014-04-16
- Last updated
- 2025-01-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02116335. Inclusion in this directory is not an endorsement.